scholarly article | Q13442814 |
P50 | author | Yen-Sung Huang | Q55266809 |
P2093 | author name string | Hsiu-Ming Shih | |
Yi-Chen Chen | |||
Cheng-Wen Wu | |||
Yu-Wei Chang | |||
Hong-Yi Kuo | |||
Chin-Hsiu Tseng | |||
P2860 | cites work | Global cancer statistics | Q22241238 |
The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein | Q24297944 | ||
PML inhibits HIF-1alpha translation and neoangiogenesis through repression of mTOR | Q24300018 | ||
AXIN is an essential co-activator for the promyelocytic leukemia protein in p53 activation | Q24306227 | ||
Tyrosine phosphorylation controls PCNA function through protein stability | Q24317732 | ||
A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to potentiate HIF-1 signaling and prostate cancer progression | Q24322269 | ||
EGFR nuclear translocation modulates DNA repair following cisplatin and ionizing radiation treatment | Q24338426 | ||
Opposing effects of PML and PML/RAR alpha on STAT3 activity | Q28198442 | ||
Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways | Q28274882 | ||
Tumor metastasis: mechanistic insights and clinical challenges | Q29617676 | ||
Immunologic therapy of multiple sclerosis | Q33540277 | ||
Nuclear epidermal growth factor receptor is a functional molecular target in triple-negative breast cancer | Q33578803 | ||
Promyelocytic leukemia protein controls cell migration in response to hydrogen peroxide and insulin-like growth factor-1 | Q33744538 | ||
Nuclear trafficking of the epidermal growth factor receptor family membrane proteins | Q33998459 | ||
COPI-mediated retrograde trafficking from the Golgi to the ER regulates EGFR nuclear transport | Q34109724 | ||
RNA helicase A is a DNA-binding partner for EGFR-mediated transcriptional activation in the nucleus | Q34136636 | ||
Dasatinib blocks cetuximab- and radiation-induced nuclear translocation of the epidermal growth factor receptor in head and neck squamous cell carcinoma | Q34283213 | ||
Loss of the tumor suppressor PML in human cancers of multiple histologic origins | Q34299352 | ||
PML-mediated signaling and its role in cancer stem cells | Q34337626 | ||
Mesenchymal Stem Cells Overexpressing IFN-β Inhibit Breast Cancer Growth and Metastases through Stat3 Signaling in a Syngeneic Tumor Model | Q34343680 | ||
The translocon Sec61beta localized in the inner nuclear membrane transports membrane-embedded EGF receptor to the nucleus | Q34352437 | ||
Nuclear translocation of epidermal growth factor receptor by Akt-dependent phosphorylation enhances breast cancer-resistant protein expression in gefitinib-resistant cells | Q35063410 | ||
Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor | Q36054625 | ||
Interleukin 6 signaling regulates promyelocytic leukemia protein gene expression in human normal and cancer cells | Q36137373 | ||
Nuclear EGFR suppresses ribonuclease activity of polynucleotide phosphorylase through DNAPK-mediated phosphorylation at serine 776. | Q36225686 | ||
Matrix metalloproteinases and tumor metastasis | Q36471104 | ||
Integrative analyses identify osteopontin, LAMB3 and ITGB1 as critical pro-metastatic genes for lung cancer. | Q36618490 | ||
Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer | Q36920432 | ||
Nuclear expression of epidermal growth factor receptor is a novel prognostic value in patients with ovarian cancer | Q37282661 | ||
Syntaxin 6-mediated Golgi translocation plays an important role in nuclear functions of EGFR through microtubule-dependent trafficking | Q37417599 | ||
Co-regulation of B-Myb expression by E2F1 and EGF receptor | Q38318606 | ||
The PML isoform IV is a negative regulator of nuclear EGFR's transcriptional activity in lung cancer | Q39170227 | ||
Multidrug-resistant cells overexpressing P-glycoprotein are susceptible to DNA crosslinking agents due to attenuated Src/nuclear EGFR cascade-activated DNA repair activity | Q39360651 | ||
Nuclear EGFR shuttling induced by ionizing radiation is regulated by phosphorylation at residue Thr654 | Q39670051 | ||
Genetic immunotherapy of lung cancer using conditionally replicating adenovirus and adenovirus-interferon-beta | Q39778480 | ||
Nuclear EGFR contributes to acquired resistance to cetuximab | Q39812008 | ||
Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway | Q40410769 | ||
Nuclear localization of EGF receptor and its potential new role as a transcription factor | Q40782527 | ||
Interferon-beta induces S phase slowing via up-regulated expression of PML in squamous carcinoma cells | Q40847270 | ||
Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line | Q41089777 | ||
Nuclear EGFR is required for cisplatin resistance and DNA repair | Q41953402 | ||
PML: An emerging tumor suppressor and a target with therapeutic potential. | Q41971647 | ||
miR‑133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP‑14. | Q45993947 | ||
Stat3 is involved in angiotensin II-induced expression of MMP2 in gastric cancer cells | Q46198272 | ||
Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis | Q47677996 | ||
Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. | Q48068389 | ||
Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma | Q48323889 | ||
Epidermal Growth Factor Receptors Control Competence to Interpret Leukemia Inhibitory Factor as an Astrocyte Inducer in Developing Cortex | Q48324514 | ||
Characterization of a novel tripartite nuclear localization sequence in the EGFR family. | Q50698452 | ||
EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF. | Q54638194 | ||
Nuclear EGFR in ductal invasive breast cancer: correlation with cyclin-D1 and prognosis. | Q54699349 | ||
Modulation of monocytes matrix metalloproteinase-2, MT1-MMP and TIMP-2 by interferon-gamma and -beta: implications to multiple sclerosis | Q78590833 | ||
Relationship between matrix metalloproteinase 2 and lung cancer progression | Q80481862 | ||
Increased expression of matrix metalloproteinase-2 (MMP-2) predicts tumour recurrence and unfavourable outcome in non-small cell lung cancer | Q80954371 | ||
Expression of KISS1 and MMP-9 in non-small cell lung cancer and their relations to metastasis and survival | Q84066257 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 19 | |
P921 | main subject | cancer metastasis | Q120912394 |
P1104 | number of pages | 11 | |
P304 | page(s) | 3132-3142 | |
P577 | publication date | 2014-01-01 | |
P1433 | published in | Cell Cycle | Q1254166 |
P1476 | title | PML represses lung cancer metastasis by suppressing the nuclear EGFR-mediated transcriptional activation of MMP2 | |
P478 | volume | 13 |